Cardiac Troponin I Levels and Alveolar-arterial Oxygen Gradient in Patients with Community-acquired Pneumonia

Heart Lung and Circulation

Volumn 19, Issue 2, 2010, Pages 90-92

  Moammar, Mahmoud Q ^a,b   Ali, Muhammad I ^a   Mahmood, Nader A ^a   DeBari, Vincent A ^b   Khan, M Anees ^a,b  

^a ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^b SETON HALL UNIVERSITY   (United States)

Author keywords

Alveolar arterial oxygen gradient; Biomarkers; Community acquired pneumonia; Myocardial stress; Troponin I

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART MUSCLE INJURY; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN; PNEUMONIA, BACTERIAL; PULMONARY ALVEOLI; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STRESS, PHYSIOLOGICAL; TROPONIN I;

EID: 74449092530     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2009.08.009     Document Type: Article

References (11)

1. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., Lewis S.A., and Macfarlane J.T. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 (2003) 377-382
2. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., Coley C.M., Marrie T.J., and Kapoor W.N. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Eng J Med 336 (1997) 243-250
3. Christ-Crain M., Stolz D., Jutla S., Couppis O., Müller C., Bingisser R., Schuetz P., Tamm M., Edwards R., Müller B., and Grossman A.B. Free and total cortisol levels as predictors as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med 176 (2007) 913-920
4. Christ-Crain M., Morgenthaler N.G., Stolz D., Müller C., Bingisser R., Harbarth S., Tamm M., Struck J., Bergmann A., and Müller B. Pro-adrenomodulin to predict severity and outcome in community-acquired pneumonia. Crit Care 10 (2006) R96 [ISRCTNO4176397]
5. Christ-Crain M., Breidthardt T., Stolz D., Zobrist K., Bingisser R., Miedinger D., Leuppi J., Tamm M., Mueller B., and Mueller C. Use of B-type natriuretic peptide in risk stratification of community-acquired pneumonia. J Intern Med 264 (2008) 166-176
6. Matsuo K., Nishikimi T., Yutani C., Kurita T., Shimizu W., Taguchi A., Suyama K., Aihara N., Kamakura S., Kangawa K., Takamiya M., and Shimomura K. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation 98 (1998) 2433-2440
7. Moammar M.Q., Azam H.M., Blamoun A.I., Rashid A.O., Ismail M., Khan M.A., and DeBari V.A. Alveolar-arterial oxygen gradient, pneumonia severity index and outcomes in patients with community-acquired pneumonia. Clin Exp Pharmacol Physiol 35 (2008) 1032-1037
8. Phua J., Koay E.S., Zhang D., Tai L.K., Boo X.L., Lim K.C., and Lim T.K. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J 28 (2006) 695-702
9. Tejera A., Santolaria F., Diez M.L., Alemán-Valls M.R., González-Reimers E., Martínez-Riera A., and Milena-Abril A. Prognosis of community-acquired pneumonia: value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 38 (2007) 117-123
10. Prat C., Lacoma A., Dominguez J., Papassotiriou J., Morgenthaler N.G., Andreo F., Tudela P., Ruiz-Manzano J., and Ausina V. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia. J Infect 55 (2007) 400-407
11. Müller B., Morgenthaler N., Stolz D., Schuetz P., Müller C., Bingisser R., Bergmann A., Tamm M., and Christ-Crain M. Circulating levels of copeptin, a novel biomarker, in lower respiratory infections. Eur J Clin Invest 37 (2007) 145-152